Dana-Farber study: Cancer vaccine shows promise for patients with stage III and IV kidney cancer (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber study: Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Caption

All nine patients treated at Dana-Farber Cancer Institute in a phase 1 trial of a personalized cancer vaccine for patients with stage III or IV kidney cancer with a high risk of recurrence, generated a successful anti-cancer immune response.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Kindly credit Dana-Farber Cancer Institute

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.